Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2019
SIETES contiene 92806 citas

 
 
 1 a 10 de 10 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Torres A, Sibila O, Ferrer M, Polverino E, Menéndez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 2015;313:677-86. [Ref.ID 98813]
2. Cita con resumen
Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, Johnson CS, Alvarez CA, Frel CR, Good C, Restrepo MI, Downs JR, Anzueto A. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA 2014;311:2199-208. [Ref.ID 97670]
3.Tiene citas relacionadas Cita con resumen
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P, for the TIOSPIR Investigators. Tiotropium respimat inhaler and the risk of death in COPD. N Engl J Med 2013;369:1. [Ref.ID 96094]
4.Tiene citas relacionadas Cita con resumen
Alíla I, de la Cal MA, Esteban A, Abella A, Ferrer R, Molina FJ, Torres A, Gordo F, Elizalde JJ, de Pablo R, Huete A, Anzueto A. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med 2011;171:1939-46. [Ref.ID 91859]
5. Cita con resumen
Schünemann HJ, Woodhead M, Anzueto A, Buist S, MacNee W, Rabe KF, Heffner J. A vision statement on guideline development for respiratory disease: the example of COPD. Lancet 2009;373:774-9. [Ref.ID 85379]
6. Cita con resumen
Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, Restrepo MI, Auger WR, Schinner R, for the NASCENT Investigation Group. Silver-coated endotracheal tube and incidence of ventilator-associated pneumonia. The NASCENT randomized trial. JAMA 2008;300:805-13. [Ref.ID 83771]
7. Cita con resumen
Anzueto A, Angel L. Update in pulmonary disease. Ann Intern Med 2000;133:360-6. [Ref.ID 52932]
8.Tiene citas relacionadas
Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Nogare A D, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S, for the NORASEPT II Study Group. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet 1998;351:929-33. [Ref.ID 37984]
9.
Anzueto A, Jubran A, Ohar JA, Piquette C A, Rennard S I, Colice G, Pattishall E N, Barrett J, Engle M, Perret K A, Rubin B K. Effects of aerosolized surfactant in patients with stable chronic bonchitis. JAMA 1997;278:1426-31. [Ref.ID 35544]
10. Cita con resumen
Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Artigas Raventós A, Lemaire F, Long W, Zaccardelli DS, Pattishall E N, for the Exosure Acute Respiratory Distress Syndrome Sepsis Study Group. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996;334:1417-21. [Ref.ID 26821]
Seleccionar todas
 
 1 a 10 de 10